Jean Philippe Chave

Learn More
BACKGROUND HIV-1-infected patients vary considerably by their response to antiretroviral treatment, drug concentrations in plasma, toxic events, and rate of immune recovery. This variability could have a genetic basis. We did a pharmacogenetics study to analyse the association between response to antiretroviral treatment and allelic variants of several(More)
· Purpose: To quantify the inflammatory reaction that can be seen in HIV-infected patients with cytomegalovirus (CMV) retinitis after the introduction of an HIV protease inhibitor and correlate it with ocular findings and systemic HIV parameters. · Methods: Report of a patient with CMV retinitis systematically followed by slit-lamp examination, funduscopy,(More)
Current evidence no longer justifies the introduction of antiretroviral treatment during primary HIV infection. Consequently, patients presenting with the acute retroviral syndrome should not be treated outside clinical studies. For patients with chronic infection, the decline of opportunistic infections, due to the efficacy of highly active antiretroviral(More)
  • 1